SCHEMBL31661607

SCHEMBL31661607

COc1ccccc1C(=O)Nc1ccc(CCOP(=O)(O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
MAPK1 P28482 4/20 0.57
RAB9A P51151 3/20 0.57
TP53 P04637 2/20 0.57
NPC1 O15118 2/20 0.57
KMT2A Q03164 5/20 0.56
ALDH1A1 P00352 3/20 0.56
KCNK3 O14649 3/20 0.54
KCNK9 Q9NPC2 3/20 0.54
KLKB1 P03952 1/20 0.54
RXFP1 Q9HBX9 1/20 0.53
KDM4E B2RXH2 2/20 0.51
LMNA P02545 1/20 0.51
AHR P35869 1/20 0.51
GFER P55789 1/20 0.51
MEN1 O00255 2/20 0.50
TSHR P16473 1/20 0.50
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13593270 1.00 MAPT (0.60) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL14062901 0.83 MAPT (0.67) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL4347151 0.81 MAPT (0.64) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL14435720 0.81 MAPT (0.64) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL4428019 0.80 MAPT (0.71) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL28133927 0.80 MAPT (0.70) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL7636114 0.79 MAPT (0.61) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL2060705 0.78 NR1H4 (0.73) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL2721612 0.77 MAPT (0.73) MAPTSMN1; SMN2MAPK1RAB9ATP53
SCHEMBL2362772 0.77 KMT2A (0.82) MAPTSMN1; SMN2MAPK1RAB9ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed